Jeffrey Bland
Jeffrey Bland is a researcher and practitioner working in the fields of functional, integrative, and personalized lifestyle medicine. His published research focuses on functional nutrition, metabolic health, and the effects of dietary supplements and polyphenols on immune function and biological markers. He also writes on the evolution of healthcare paradigms, including nutrition education in medical schools and personalized wellness interventions.
21 claims checked on air: 5 context 3 contradicted 2 overstated 3 supported 8 unverified
What they said on air - contradicted
3 citing their own research
The cells that make up the human immune system turn over and are replaced with new cells every 90 to 120 days.
"So, when we start thinking about the immune system, it has this dynamic personality because it turns over about every 90 to 120 days. Every 3 to 4 months the cells that make up our immune system get replaced with new cells." (said at 0:05:49)
The claim that the human immune system turns over completely every 90 to 120 days confuses the lifespan of red blood cells (erythrocytes, which are non-immune oxygen-transporting cells that famously survive about 120 days) with immune cells (leukocytes).
In reality, different immune cells have vastly different lifespans and turnover rates rather than a single uniform 90-to-120-day replacement cycle:
- Neutrophils (the most abundant type of white blood cell) turn over very rapidly, living for only hours to a few days.
- Naive T and B lymphocytes are long-lived interphase cells, with naive B cells proliferating at very low rates (about 0.46% per day) and naive/memory T cell populations maintained across decades.
- Memory immune cells, including memory T cells and stem cell-like memory T (TSCM) cells, undergo ongoing proliferation and dynamic flux over years or decades to maintain long-term immunological memory.
Because different immune cell lineages range from a lifespan of hours (neutrophils) to decades (memory T cells), there is no 90-to-120-day turnover cycle for the human immune system.
- contradicts: B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. (Blood 2005) · cited 195x in the literature
"We show that total blood B cells of young adults divide at an average rate of 1.9% (+/-1.0%) per day and at a similar though slightly slower rate, 1.5% (+/-1.3%) per day, in the elderly. Separation of naive and memory B cells according to expression of CD27 indicates that naive peripheral blood B cells divide slowly (0.46% per day), while memory cells proliferate more rapidly (2.66% per day)." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic Flux. (Cell reports 2016) · cited 85x in the literature
"Collectively, these observations show that T SCM cells exist in a state of perpetual flux throughout the human lifespan." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Lifespans of naive, memory and effector lymphocytes. (Current opinion in immunology 1993) · cited 133x in the literature
"The bulk of mature T and B cells are immunologically naive and remain in interphase for prolonged periods. Contact with specific antigen causes these naive cells to proliferate rapidly and differentiate into a mixture of short-lived effector cells and long-lived memory cells." (abstract, passage verified)
pubmedfull study (doi)
Bruce McEwen was the first researcher to investigate the relationship between the immune system and insulin resistance.
"If you look at his body of work, he was the first person to start looking at the relationship between the immune system and insulin resistance." (said at 0:51:45)
Bruce McEwen was a prominent neuroendocrinologist renowned for discovering glucocorticoid receptors in the hippocampus and developing the concepts of allostasis and allostatic load, which integrate stress, the neuroendocrine system, and systemic physiology. However, he was not the first researcher to investigate the relationship between the immune system and insulin resistance. The seminal experimental work linking immune mediators to insulin resistance was pioneered in the early 1990s by Gökhan Hotamisligil, Bruce Spiegelman, and colleagues (e.g., demonstrating that tumor necrosis factor-alpha [TNF-α] directly induces insulin resistance in obesity, published in Science in 1993), which founded the field of immunometabolism. Earlier clinical and physiological investigations into infection- and endotoxin-induced insulin resistance also predated McEwen's later conceptual syntheses.
Jeffrey Friedman discovered the hormone leptin in Bruce McEwen's laboratory.
"in his lab, Jeff Friedman discovered leptin." (said at 0:52:36)
Jeffrey Friedman discovered leptin in 1994 as the head of his own laboratory at The Rockefeller University / Howard Hughes Medical Institute, not in Bruce McEwen's laboratory. While both were faculty members at Rockefeller University, the positional cloning and identification of the obese (ob) gene and its hormone product, leptin, was achieved by Friedman's own research group (Zhang et al., 1994).
Fact-checked episodes
Publications
- Artificial Intelligence-Artificial Wisdom Medicine, Meaning, and the Impact of Artificial Intelligence.Integrative medicine (Encinitas, Calif.) 2026 · CEBM Level 5
- Nutrition Education in Medical School: What Should It Include?Integrative medicine (Encinitas, Calif.) 2026 · CEBM Level 5
- A proposal to "Whole" our knowing: Clinical medicine in the Noosphere.Explore (New York, N.Y.) 2025 · CEBM Level 5
- The Paradigm-Shifting Future of Health Care: Rise of Predictive, Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2025 · CEBM Level 5
- Treating Metabolic Syndrome: P4 Medicine Meets Functional Medicine.Phenomics (Cham, Switzerland) 2025 · CEBM Level 5
- The impact of a polyphenol-rich supplement on epigenetic and cellular markers of immune age: a pilot clinical study.Frontiers in nutrition 2024 · CEBM Level 4
- LIFEHOUSE's Functional Nutrition Examination (Physical Exam, Anthropometrics, and Selected Biomarkers) Informs Personalized Wellness Interventions.Journal of personalized medicine 2023 · CEBM Level 4
- Personalized Lifestyle Intervention and Functional Evaluation Health Outcomes SurvEy: Presentation of the LIFEHOUSE Study Using N-of-One Tent-Umbrella-Bucket Design.Journal of personalized medicine 2022 · CEBM Level 5
- Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine.Nutrients 2022 · CEBM Level 5
- Clinical Understanding of the Sleep-Immune Connection.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Functional Medicine Past, Present, and Future .Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Our Healing Journey: Restoring Connection, Finding Hope and Evolving Wellness.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Therapeutic Use of Omega-3 Fatty Acids for Immune Disorders In Search of the Ideal Omega-3 Supplement .Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Glutathione, Orthomolecular Medicine, and Nutraceutical Therapy.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Why the Pegan Diet Makes Sense.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- COVID-19 Risk: Clinical Tools for Assessing and Personalizing Immunity.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- A Discovery that Reframes the Whole of Global Healthcare in the 21st Century: The Importance of the Imprintome.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Application of Phytochemicals in Immune Disorders: Their Roles Beyond Antioxidants.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Prostate Cancer Risk Connection to Immunity, Hormones, and the Microbiome.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Spaceship Earth Revisited: The Co-Benefits of Overcoming Biological Extinction of Experience at the Level of Person, Place and Planet.International journal of environmental research and public health 2020 · CEBM Level 5
- What is the Best Way to Assess Functional Health?: The History of the Development and Application of the Patient Reported Outcome Measurement Information System (PROMIS).Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- Reflections on the COVID-19 Pandemic.Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- Bitter Taste Receptor Ligand Improves Metabolic and Reproductive Functions in a Murine Model of PCOS.Endocrinology 2019 · CEBM Level 5
- Fasting Physiology and Therapeutic Diets: A Look Back to the Future.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- The Dark Matter of Nutrition: Dietary Signals Beyond Traditional Nutrients .Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Eighth Annual Conference of inVIVO Planetary Health: From Challenges to Opportunities.International journal of environmental research and public health 2019 · CEBM Level 5
- What is Evidence-Based Functional Medicine in the 21st Century?Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Linus Pauling (1901-1994).Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- In Defense of Direct-to-Consumer Genetic Testing.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Systems Biology Meets Functional Medicine.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Notes from a Functional Medicine Watcher.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- The Evolution of Personalized Nutrition-From Addis, Pauling, and RJ Williams to the Future.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits.Molecular metabolism 2018 · CEBM Level 5
- The Natural Roots of Functional Medicine.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age-related Disease: A Revolution Is Coming.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age-related Disease: A Revolution is Coming, Part 2-Dietary Acid Load, Hypertension, and Cardiovascular Disease.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age as a Modifiable Risk Factor for Chronic Disease.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Making Genetic Testing More Clinically Valuable.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Creating Health in America, One Person at a Time: A Message for Incoming President Trump.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Defining Function in the Functional Medicine Model.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans.Frontiers in endocrinology 2017 · CEBM Level 4
- Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans.Journal of the Endocrine Society 2017 · CEBM Level 4
- Cardiac Lymphatics: An Example of Systems Biology in Medicine.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Chronic Fatigue Syndrome, Functional Mitochondriopathy, and Enterohepatic Dysfunction.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Cardiology Meets Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Mild Cognitive Impairment, Neurodegeneration, and Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Where Is Health Care Headed?Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- The Gut Mucosal Firewall and Functional Medicine.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Intestinal Microbiome, Akkermansia muciniphila , and Medical Nutrition Therapy.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Kidney Disease: Personalized Lifestyle Health Care Makes a Big Difference.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Functional Medicine: An Operating System for Integrative Medicine.Integrative medicine (Encinitas, Calif.) 2015 · CEBM Level 5
- When Is a Disease a "Disease"?Integrative medicine (Encinitas, Calif.) 2015 · CEBM Level 5
- KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes.PloS one 2014 · CEBM Level 5
- META060 protects against diet-induced obesity and insulin resistance in a high-fat-diet fed mouse.Nutrition (Burbank, Los Angeles County, Calif.) 2013 · CEBM Level 5
- Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations.TheScientificWorldJournal 2013 · CEBM Level 5
- Jeffrey Bland, Phd, FACN, FACB: heart disease, inflammation, and the revolution in health care. Interview by Craig Gustafson.Alternative therapies in health and medicine 2013 · CEBM Level 5
- META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.Atherosclerosis 2012 · CEBM Level 5
- Isolation of bitter acids from hops (Humulus lupulus L.) using countercurrent chromatography.Journal of separation science 2012 · CEBM Level 5
- Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice.Nutrition research and practice 2012 · CEBM Level 5
- The Heart and Medicine: Exploring the Interconnectedness of Cardiometabolic-related Concerns Through a Systems Biology Approach.Global advances in health and medicine 2012 · CEBM Level 5
- The Effects of Tetrahydro-iso-alpha Acids and Niacin on Monocyte-Edothelial Cell Interactions and Flow-mediated Vasodilation.Global advances in health and medicine 2012 · CEBM Level 2
- Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome.Nutrition research (New York, N.Y.) 2011 · CEBM Level 2
- A program consisting of a phytonutrient-rich medical food and an elimination diet ameliorated fibromyalgia symptoms and promoted toxic-element detoxification in a pilot trial.Alternative therapies in health and medicine 2011 · CEBM Level 3
- Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial.Journal of bone and mineral metabolism 2010 · CEBM Level 2
- META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.Arthritis and rheumatism 2010 · CEBM Level 5
- Cancers as systemic functional diseases, Part 2: clinical implications.Alternative therapies in health and medicine 2010 · CEBM Level 5
- Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice.Journal of medicinal food 2010 · CEBM Level 5
- Hop and Acacia Phytochemicals Decreased Lipotoxicity in 3T3-L1 Adipocytes, db/db Mice, and Individuals with Metabolic Syndrome.Journal of nutrition and metabolism 2010 · CEBM Level 2
- Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins.Journal of clinical lipidology 2010 · CEBM Level 2
- A science-based, clinically tested dietary approach for the metabolic syndrome.Metabolic syndrome and related disorders 2009 · CEBM Level 5
- Rho iso-alpha acids from hops inhibit the GSK-3/NF-kappaB pathway and reduce inflammatory markers associated with bone and cartilage degradation.Journal of inflammation (London, England) 2009 · CEBM Level 5
- Functional somatic syndromes, stress pathologies, and epigenetics.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Does complementary and alternative medicine represent only placebo therapies?Alternative therapies in health and medicine 2008 · CEBM Level 5
- Systems biology, functional medicine, and folates.Alternative therapies in health and medicine 2008 · CEBM Level 5
- The importance of functional biomarkers in the management of chronic illness.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Dietary management of the metabolic syndrome beyond macronutrients.Nutrition reviews 2008 · CEBM Level 5
- The future of nutritional pharmacology.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial.Nutrition & metabolism 2008 · CEBM Level 2
- Autism: asking the right questions to find the right answers.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Managing biotransformation: introduction and overview.Alternative therapies in health and medicine 2007 · CEBM Level 5
- A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals.Nutrition reviews 2007 · CEBM Level 5
- Acid-alkaline balance: role in chronic disease and detoxification.Alternative therapies in health and medicine 2007 · CEBM Level 5
- Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions.Canadian journal of physiology and pharmacology 2007 · CEBM Level 2
- Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.Nutrition (Burbank, Los Angeles County, Calif.) 2006 · CEBM Level 2
- Alternative therapies--a moving target.Alternative therapies in health and medicine 2005 · CEBM Level 5
- Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial.Alternative therapies in health and medicine 2005 · CEBM Level 4
- A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia.Phytotherapy research : PTR 2005 · CEBM Level 4
- Biomarkers of aging: from primitive organisms to humans.The journals of gerontology. Series A, Biological sciences and medical sciences 2004 · CEBM Level 5
- Jeffrey S. Bland, PhD, FACN, CNS: functional medicine pioneer.Alternative therapies in health and medicine 2004 · CEBM Level 5